Estados financieros detallados de Rallybio Corporation (RLYB): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto -11.1%, margen operativo -36.7%, margen neto 70.5%.
Al precio actual de $17.09, RLYB cotiza a un P/E de 2.14 y un ROE del 68.56%. La capitalización bursátil es de $91M.
Cuenta de Resultados (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | $636000 | $858000 |
| Coste de Ventas | $26344 | $62030 | $109000 | 0 | $150000 | $39.5M | $92000 |
| Beneficio Bruto | -$26344 | -$62030 | -$109000 | 0 | -$150000 | -$38.9M | $766000 |
| I+D | $11.4M | $17.6M | $26.9M | $40.7M | $53.5M | $41.5M | $19.6M |
| Generales y Administrativos | $6.3M | $7.7M | $18.7M | $27.2M | $25.4M | $18.3M | $14.3M |
| Gastos Operativos | $17.6M | $25.3M | $45.6M | $67.9M | $78.9M | $21.6M | $28.8M |
| Beneficio Operativo | -$17.6M | -$25.3M | -$45.6M | -$67.9M | -$78.9M | -$60.5M | -$28.1M |
| EBITDA | -$17.4M | -$25.2M | -$45.4M | -$67.7M | -$78.8M | -$60.4M | -$28.0M |
| Gastos por Intereses | $39000 | $49000 | $10000 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$17.5M | -$26.5M | -$47.0M | -$66.7M | -$74.6M | -$57.8M | -$9.0M |
| Impuestos | 0 | -$15000 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$17.6M | -$26.4M | -$47.0M | -$66.7M | -$74.6M | -$57.8M | -$9.0M |
| BPA | $-4.40 | $-9.52 | $-11.68 | $-16.72 | $-14.72 | $-10.64 | $-1.59 |
| BPA Diluido | $-6.32 | $-9.52 | $-11.68 | $-16.72 | $-14.72 | $-10.64 | $-1.59 |
| Acciones en Circulación (Diluidas) | $2.8M | $2.8M | $4.0M | $4.0M | $5.1M | $5.4M | $5.6M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $212000 | $222000 | $212000 | 0 |
| Beneficio Bruto | -$3.9M | -$3.4M | $209000 | 0 |
| Beneficio Operativo | -$6.9M | -$6.4M | -$4.7M | -$5.7M |
| EBITDA | -$6.9M | -$6.4M | -$4.7M | $45.0M |
| Beneficio Neto | $16.0M | -$5.9M | -$8.3M | $43.7M |
| BPA | $2.84 | $-1.11 | $-1.46 | $7.66 |
| BPA Diluido | $2.84 | $-1.11 | $-1.46 | $7.53 |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $19.5M | $140.2M | $175.3M | $57.0M | $24.5M | $13.9M | $31.4M |
| Inversiones a Corto | 0 | 0 | 0 | $112.0M | $85.4M | $51.6M | $23.4M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $20.9M | $141.3M | $180.9M | $179.5M | $114.8M | $67.8M | $61.3M |
| Inmovilizado Material | $199000 | $287000 | $511000 | $909000 | $592000 | $267000 | $198000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $21.6M | $141.9M | $182.2M | $180.4M | $115.6M | $68.1M | $62.3M |
| Cuentas por Pagar | $857000 | $1.6M | $603000 | $1.1M | $976000 | $278000 | $126000 |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $3.8M | $5.8M | $6.6M | $10.7M | $9.3M | $6.2M | $4.2M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $4.7M | $5.9M | $6.6M | $11.1M | $9.4M | $6.5M | $4.3M |
| Reservas | -$20.6M | -$47.0M | -$94.0M | -$160.7M | -$235.2M | -$293.0M | -$302.0M |
| Patrimonio Neto | $16.9M | $136.0M | $175.6M | $169.3M | $106.2M | $61.7M | $58.0M |
| Deuda Total | 0 | 0 | 0 | $555000 | $392000 | $154000 | $176000 |
| Deuda Neta | -$19.5M | -$140.2M | -$175.3M | -$168.4M | -$109.5M | -$65.4M | -$54.6M |
| Capital Circulante | $17.1M | $135.4M | $174.3M | $168.8M | $105.5M | $61.6M | $57.0M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $32.1M | $31.4M | $41.3M | $92.8M |
| Activos Totales | $67.7M | $62.3M | $54.5M | $98.1M |
| Pasivos Totales | $4.6M | $4.3M | $4.2M | $3.6M |
| Patrimonio Neto | $63.0M | $58.0M | $50.3M | $94.5M |
| Deuda Total | $198000 | $176000 | $154000 | 0 |
Flujo de Caja (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$17.6M | -$26.4M | -$47.0M | -$66.7M | -$74.6M | -$57.8M | -$9.0M |
| Amortizaciones | $26000 | $62000 | $109000 | $167000 | $150000 | $131000 | $92000 |
| Compensación en Acciones | $194000 | $704000 | $3.6M | $9.5M | $10.9M | $8.0M | $5.3M |
| Cambio en Capital Circulante | $2.1M | $2.1M | -$3.8M | -$936000 | $4.3M | -$258000 | -$4.2M |
| Flujo de Caja Operativo | -$15.0M | -$22.0M | -$45.5M | -$57.3M | -$60.3M | -$49.3M | -$29.8M |
| Inversiones (CapEx) | -$188000 | -$137000 | -$333000 | -$54000 | -$12000 | 0 | 0 |
| Adquisiciones | 0 | -$1.9M | -$2.0M | -$300000 | -$2.2M | -$2.0M | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$15.2M | -$22.2M | -$45.9M | -$57.3M | -$60.3M | -$49.3M | -$29.8M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$6.5M | -$4.7M | -$8.0M | $45.5M |
| Inversiones (CapEx) | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$6.5M | -$4.7M | -$8.0M | $45.5M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $1.0M | $774000 | $613000 | $424000 |
Crecimiento y Márgenes (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | | | | | +34.9% |
| Crecimiento Beneficio Neto (anual) | | -50.0% | -77.8% | -41.8% | -11.9% | +22.5% | +84.5% |
| Crecimiento BPA (anual) | | -116.4% | -22.7% | -43.2% | +12.0% | +27.7% | +85.1% |
| Cambio en Acciones (anual) | | +0.0% | +44.4% | -1.0% | +27.1% | +7.7% | +3.4% |
| Crecimiento FCF (anual) | | -45.8% | -106.8% | -25.0% | -5.1% | +18.2% | +39.5% |
| Margen Bruto | | | | | | -6111.8% | 89.3% |
| Margen Operativo | | | | | | -9511.9% | -3270.9% |
| Margen EBITDA | | | | | | -9491.4% | -3260.1% |
| Margen Neto | | | | | | -9084.1% | -1046.4% |
| Margen FCF | | | | | | -7748.7% | -3474.7% |
| Tasa Impositiva Efectiva | -0.0% | 0.1% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-5.47 | $-7.98 | $-11.42 | $-14.41 | $-11.92 | $-9.05 | $-5.30 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $2.8M | $2.8M | $4.0M | $4.0M | $5.1M | $5.4M | $5.6M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | 68.56% |
| Rentabilidad sobre capital invertido | -24.40% |
| Rentabilidad sobre activos | 46.45% |
| Margen bruto | -1107.59% |
| Margen operativo | -3672.29% |
| Margen neto | 7051.24% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 27.26 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -2.86 |
Ratios Clave (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -25.64 | -11.85 | -6.53 | -3.14 | -1.30 | -0.72 | -3.45 |
| P/VC | 18.60 | 2.31 | 1.75 | 1.23 | 0.91 | 0.68 | 0.53 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 65.73 | 36.02 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -6111.8% | 89.3% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -9511.9% | -3270.9% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -9084.1% | -1046.4% |